The leading representative office of defined VC is situated in the Taipei. The fund was located in Asia if to be more exact in Taiwan.
Among the most popular portfolio startups of the fund, we may highlight Polaris Networks, Serenex, Broncus Technologies. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in some founders of portfolio startups. Among the most popular fund investment industries, there are Biotechnology, Software. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
Comparing to the other companies, this Pac-Link performs on 4 percentage points more the average number of lead investments. The top amount of exits for fund were in 2014. Considering the real fund results, this VC is 7 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2007. The fund is constantly included in less than 2 deals per year.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Pac-Link, startups are often financed by Menlo Ventures, Abingworth, Silverton Partners. The meaningful sponsors for the fund in investment in the same round are Abingworth, Sunsino Ventures Group, Skypoint Capital. In the next rounds fund is usually obtained by BDC Venture Capital, SK Telecom, NovaQuest.
The overall number of key employees were 1.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Synerchip | $10M | 20 Apr 2010 | Sunnyvale, California, United States | ||
UltiZen | $6M | 05 Aug 2008 | Shanghai | ||
Portola Pharmaceuticals | $60M | 01 Jul 2008 | South San Francisco, California, United States | ||
$24M | 16 Apr 2007 | San Francisco, California, United States | |||
Trellis Bioscience | $10M | 14 Feb 2007 | San Francisco, California, United States | ||
$10M | 21 Dec 2006 | New Taipei | |||
Bayhill Therapeutics | $35M | 04 May 2005 | California, United States | ||
Polaris Networks | $52M | 18 Mar 2002 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Synerchip | $10M | 20 Apr 2010 | Sunnyvale, California, United States | ||
UltiZen | $6M | 05 Aug 2008 | Shanghai | ||
Portola Pharmaceuticals | $60M | 01 Jul 2008 | South San Francisco, California, United States | ||
$24M | 16 Apr 2007 | San Francisco, California, United States | |||
Trellis Bioscience | $10M | 14 Feb 2007 | San Francisco, California, United States | ||
$10M | 21 Dec 2006 | New Taipei | |||
Bayhill Therapeutics | $35M | 04 May 2005 | California, United States | ||
Polaris Networks | $52M | 18 Mar 2002 | Massachusetts, United States |